Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

The RESHAPE-HF2 trial showed that mitral transcatheter edge-to-edge repair (M-TEER) has an advantage over guideline-recommended medical therapy alone, and the MATTERHORN trial showed M-TEER to be ...

The much-anticipated RESHAPE-HF2 trial aimed to clarify the role of transcatheter edge-to-edge repair (TEER) with the MitraClip device in patients with heart failure with functional mitral ...

The RESHAPE-HF2 (Randomized Investigation of the MitraClip Device in Heart Failure [HF]: Second Trial in Patients With Clinically Significant Functional Mitral Regurgitation [MR]) trial assessed the ...

As shown above, new products are also coming: the Hoover HF2 cordless vacuum, HF4 Hydro (which features a dedicated new head attachment), and Wet & Dry HW5 vac.